Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference
Acrivon Therapeutics' president and CEO Peter Blume-Jensen, M.D., Ph.D., will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference in New York on Wednesday, September 9, 2026, at 8:35 a.m. ET. A live and archived webcast will be accessible through the Events & Presentations page of the company's investor website.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.